AGE DEPENDENT CONTROL OF VASCULAR SMOOTH MYOCYTE GROWTH
血管平滑肌细胞生长的年龄依赖性控制
基本信息
- 批准号:2501706
- 负责人:
- 金额:$ 8.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-09-30 至 1999-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Aging is a major risk for atherosclerosis. Abnormal proliferation of
vascular smooth muscle cells (VSMCs) is an integral part of
atherosclerotic plaque formation. Recent studies performed in my
laboratory have shown the temporally and spatially coordinated
induction of cdk2 and its regulatory subunits, cyclins E and A, after
angioplasty in the rat carotid artery. Expression of these factors was
also seen in proliferating VSMCs within human restenotic lesions,
suggesting that induction of cdks and cyclins may contribute to
pathological VSMC growth in injured human arteries. Induction of the
cdk inhibitor p27, through suppression of cdk2 activity and
transcriptional repression of cyclin A gene expression, might limit
VSMC growth at late time points after angioplasty, and adenovirus-
mediated overexpression of p27 after angioplasty reduced intimal lesion
formation. We have also shown that elements within the -209 to +79
cyclin E and -79 to +100 cyclin A promoter regions confer cell cycle-
dependent transcriptional control in VSMCs.
Previous studies by others have demonstrated that the proliferative
response of VSMCs to balloon angioplasty is enhanced in aged rats,
suggesting that age-related increased VSMC growth kinetics might
contribute-to the increasing prevalence and severity of atherosclerosis
seen with aging. The broad objective of this Proposal is to elucidate
age-dependent changes in the cell-cycle machinery in VSMCs that may
contribute to enhanced atherosclerosis with aging. The investigations
outlined in Specific Aim I will characterize the kinetics of expression
and activity of cell-cycle regulatory factors after angioplasty in
young and old rats. The studies outlined in Specific Aim 2 will
elucidate age-related changes in the transcriptional regulation of
cyclin E and A gene expression in VSMCs. Investigations outlined in
Specific Aim 3 will assess the relevance of p27 to VSMC growth and
intimal lesion formation in young and old animals. These studies will
include gain-of function experiments using an adenovirus vector
directing the overproduction of p27, and loss-of function studies using
p27-deficient mice. These studies should yield valuable mechanistic
insights into the cell-cycle regulatory networks underlying age-related
increased VSMC proliferation and, ultimately, enhanced intimal lesion
formation seen with aging.
衰老是动脉粥样硬化的主要风险。异常增殖
血管平滑肌细胞(VSMC)是血管平滑肌细胞的一个组成部分,
动脉粥样硬化斑块形成。最近的研究在我的
实验室已经证明了时间和空间协调
诱导cdk 2及其调节亚基,细胞周期蛋白E和A,
大鼠颈动脉血管成形术。这些因素的表达是
也见于人再狭窄病变内增殖的VSMC,
提示cdks和cyclins的诱导可能有助于
病理性VSMC生长在受伤的人动脉中。诱导
CDK抑制剂p27,通过抑制CDK 2活性,
细胞周期蛋白A基因表达的转录抑制,可能会限制
血管成形术后晚期VSMC生长,腺病毒-
血管成形术后p27介导的过度表达减少了内膜损伤
阵我们还证明了-209到+79范围内的元素
细胞周期蛋白E和-79到+100细胞周期蛋白A启动子区赋予细胞周期-
VSMCs中的依赖性转录控制。
其他人先前的研究表明,
老年大鼠血管平滑肌细胞对球囊血管成形术的反应增强,
提示年龄相关的VSMC生长动力学增加可能
导致动脉粥样硬化的患病率和严重程度增加
看到了衰老。本提案的总体目标是阐明
VSMC细胞周期机制的年龄依赖性变化,
导致动脉粥样硬化随着年龄的增长而增强。调查
具体目标I中概述的方法将表征表达的动力学
血管成形术后细胞周期调节因子的活性
年轻和年老的老鼠具体目标2中概述的研究将
阐明与年龄相关的转录调控的变化,
细胞周期蛋白E和A基因表达。概述的调查
具体目标3将评估p27与VSMC生长的相关性,
年轻和老年动物内膜损伤形成。这些研究将
包括使用腺病毒载体功能获得实验
指导p27的过度产生,以及使用
p27缺陷小鼠。这些研究应该产生有价值的机制
深入了解与年龄相关的细胞周期调控网络
VSMC增殖增加,最终内膜损伤增强
随着年龄的增长而形成。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Age-dependent increase in c-fos activity and cyclin A expression in vascular smooth muscle cells. A potential link between aging, smooth muscle cell proliferation and atherosclerosis.
- DOI:10.1016/s0008-6363(99)00385-5
- 发表时间:2000-03
- 期刊:
- 影响因子:10.8
- 作者:A. Rivard;N. Principe;V. Andrés
- 通讯作者:A. Rivard;N. Principe;V. Andrés
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VINCENTE ANDRES其他文献
VINCENTE ANDRES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VINCENTE ANDRES', 18)}}的其他基金
RESTENOSIS AND CONTROL OF VASCULAR MYOCYTE PROLIFERATION
再狭窄和血管心肌细胞增殖的控制
- 批准号:
5200080 - 财政年份:1997
- 资助金额:
$ 8.22万 - 项目类别:
RESTENOSIS AND CONTROL OF VASCULAR MYOCYTE PROLIFERATION
再狭窄和血管心肌细胞增殖的控制
- 批准号:
2397719 - 财政年份:1997
- 资助金额:
$ 8.22万 - 项目类别:
RESTENOSIS AND CONTROL OF VASCULAR MYOCYTE PROLIFERATION
再狭窄和血管心肌细胞增殖的控制
- 批准号:
2771550 - 财政年份:1997
- 资助金额:
$ 8.22万 - 项目类别:
相似海外基金
MRC TS Award: Regulation of neutrophil functions by cell cycle proteins
MRC TS 奖:细胞周期蛋白调节中性粒细胞功能
- 批准号:
MR/X023087/1 - 财政年份:2023
- 资助金额:
$ 8.22万 - 项目类别:
Fellowship
Cell cycle proteins as key regulators of cardiac chemosensitivity
细胞周期蛋白作为心脏化疗敏感性的关键调节因子
- 批准号:
10353398 - 财政年份:2021
- 资助金额:
$ 8.22万 - 项目类别:
Cell cycle proteins as key regulators of cardiac chemosensitivity
细胞周期蛋白作为心脏化疗敏感性的关键调节因子
- 批准号:
10558622 - 财政年份:2021
- 资助金额:
$ 8.22万 - 项目类别:
Regulation of neutrophil functions by cell cycle proteins
细胞周期蛋白对中性粒细胞功能的调节
- 批准号:
MR/R02149X/1 - 财政年份:2018
- 资助金额:
$ 8.22万 - 项目类别:
Fellowship
Role of Musashi in the regulation of cell cycle proteins
Musashi 在细胞周期蛋白调节中的作用
- 批准号:
DP120100224 - 财政年份:2012
- 资助金额:
$ 8.22万 - 项目类别:
Discovery Projects
Interaction between HIV-1 and cell cycle proteins
HIV-1 和细胞周期蛋白之间的相互作用
- 批准号:
6594793 - 财政年份:2002
- 资助金额:
$ 8.22万 - 项目类别:
REGULATION OF CELL CYCLE PROTEINS DURING ANGIOGENESIS
血管生成过程中细胞周期蛋白的调节
- 批准号:
6497933 - 财政年份:2002
- 资助金额:
$ 8.22万 - 项目类别:
Interaction between HIV-1 and cell cycle proteins
HIV-1 和细胞周期蛋白之间的相互作用
- 批准号:
6608078 - 财政年份:2002
- 资助金额:
$ 8.22万 - 项目类别: